# Surefire Institutional DEB-TACE

> **NCT03211598** · NA · UNKNOWN · sponsor: **Alexander Kim** · enrollment: 15 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** TACE with Surefire

## Key facts

- **NCT ID:** NCT03211598
- **Lead sponsor:** Alexander Kim
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2020-04
- **Final completion:** 2020-04
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03211598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03211598, "Surefire Institutional DEB-TACE". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03211598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*